MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy

Stefan Heinrichs1, Lillian F Conover, Carlos E Bueso-Ramos

  • 1Institute of Transfusion Medicine , University Hospital Essen , Essen , Germany ; Department of Pediatric Oncology , Dana-Farber Cancer Institute , Boston , United States.

Elife
|July 24, 2013
PubMed

Insights

Reduced MYBL2 gene activity, not just haploinsufficiency, drives clonal expansion in myeloid malignancies like myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). This finding impacts understanding of these blood cancers.

Area of Science:

  • Hematology
  • Cancer Biology
  • Genetics

Background:

  • A common deleted region on chromosome 20 (20q CDR) is implicated in myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).
  • This region is predicted to harbor a tumor suppressor gene crucial for hematopoiesis.

Purpose of the Study:

  • To investigate the role of the MYBL2 gene, located within the 20q CDR, in myeloid malignancies.
  • To determine if reduced MYBL2 expression contributes to the pathogenesis of MDS and MPN.

Main Methods:

  • Assessed MYBL2 expression levels in CD34+ cells from MDS patients.
  • Utilized a murine competitive reconstitution model with RNA interference (RNAi) to knockdown Mybl2 expression in hematopoietic progenitors.
  • Analyzed hematopoietic reconstitution and disease development in transplanted mice.

Main Results:

  • MYBL2 was expressed at significantly reduced levels in CD34+ cells from a majority of MDS patients (65%).
  • Mybl2 knockdown (20-30% of normal) in murine hematopoietic progenitors led to their clonal dominance.
  • Mice transplanted with Mybl2-downregulated cells developed clonal myeloproliferative/myelodysplastic disorders.

Conclusions:

  • Downregulation of MYBL2 activity below classical haploinsufficiency levels drives clonal expansion of hematopoietic progenitors.
  • Reduced MYBL2 function is a key mechanism underlying a significant fraction of human myeloid malignancies.
  • MYBL2 is a critical tumor suppressor in hematopoiesis, and its reduced activity contributes to MDS and MPN development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...